MYNZ

Mainz Biomed N.V.

Insider trading activity for Mainz Biomed N.V., straight from SEC Form 4 filings. Net figures below count open-market buys and sales only — grants, option exercises and tax withholding are excluded because they are compensation, not decisions to trade.

Past 3 months

net buying

Bought(0 · 0 insiders): $0
Sold(0 · 0 insiders): $0

Past 6 months

net buying

Bought(0 · 0 insiders): $0
Sold(0 · 0 insiders): $0

Past 12 months

net buying

Bought(0 · 0 insiders): $0
Sold(0 · 0 insiders): $0

Transaction history

The 32 most recent Form 4 transactions.

Open in screener →

Insider transactions, newest first: date, security, transaction type, size and a link to the filing each row came from.
Date	Insider	Role	Type	Shares	Price	Value	Δ Own	Filing
Aug 11	Caragol William J	Chief Financial Officer	AGRANT◆	212,500	—	—	—	Open the original filing on SEC.gov
Aug 5	Lazar David E.	Chief Executive Officer	CCONV◆	124,700	—	—	—	Open the original filing on SEC.gov
Aug 5	Lazar David E.	Chief Executive Officer	CCONV◆	1M	—	—	—	Open the original filing on SEC.gov
Aug 5	Lazar David E.	Chief Executive Officer	CCONV◆	1M	—	—	—	Open the original filing on SEC.gov
Aug 5	Lazar David E.	Chief Executive Officer	CCONV◆	1M	—	—	—	Open the original filing on SEC.gov
Aug 5	Lazar David E.	Chief Executive Officer	CCONV⚠	28.1M	$225.00	$6.3B	+103.9%	Open the original filing on SEC.gov
Aug 5	Lazar David E.	Chief Executive Officer	CCONV	9M	$9.00	$81M	+50.0%	Open the original filing on SEC.gov
Aug 5	Lazar David E.	Chief Executive Officer	CCONV	9M	$9.00	$81M	+100.0%	Open the original filing on SEC.gov
Aug 5	Lazar David E.	Chief Executive Officer	CCONV	9M	$9.00	$81M	—	Open the original filing on SEC.gov
Jul 31	O'Rourke Peter	Director	AGRANT◆	190,840	—	—	—	Open the original filing on SEC.gov
Jul 31	Natan David	Director	AGRANT◆	190,840	—	—	—	Open the original filing on SEC.gov
Jul 31	Caragol William J	Chief Financial Officer	AGRANT◆	212,500	—	—	—	Open the original filing on SEC.gov
Jul 31	Buffalino Louis R.	Director	AGRANT◆	425,000	—	—	—	Open the original filing on SEC.gov
Jul 31	Ben-Tzvi Avraham	Director	AGRANT	112,259	—	—	+80.7%	Open the original filing on SEC.gov
Jul 22	O'Rourke Peter	Director	AGRANT◆↺	191,860	—	—	—	Open the original filing on SEC.gov
Jul 22	Natan David	Director	AGRANT◆↺	191,860	—	—	—	Open the original filing on SEC.gov
Jul 22	Caragol William J	Chief Financial Officer	AGRANT◆↺	212,500	—	—	—	Open the original filing on SEC.gov
Jul 22	Buffalino Louis R.	Director	AGRANT◆↺	425,000	—	—	—	Open the original filing on SEC.gov
Jul 22	Ben-Tzvi Avraham	Director	AGRANT↺	112,859	—	—	+81.1%	Open the original filing on SEC.gov
Jul 6	O'Rourke Peter	Director	AGRANT◆	112,859	—	—	—	Open the original filing on SEC.gov
May 8	Natan David	Director	AGRANT	137,141	—	—	—	Open the original filing on SEC.gov
May 8	Ben-Tzvi Avraham	Director	AGRANT	137,141	—	—	+6,857%	Open the original filing on SEC.gov
Apr 22	Lazar David E.	Chief Executive Officer	AGRANT◆	1M	$1.50	$1.5M	—	Open the original filing on SEC.gov
Apr 22	Lazar David E.	Chief Executive Officer	AGRANT◆	1M	$1.50	$1.5M	—	Open the original filing on SEC.gov
Feb 13	Tibbitts Gregory J	Director	AGRANT	45,000	—	—	+413.8%	Open the original filing on SEC.gov
Feb 13	Dreismann Heinrich	Director	AGRANT	45,000	—	—	+228.4%	Open the original filing on SEC.gov
Feb 13	Caragol William J	Chief Financial Officer	AGRANT	290,000	—	—	+372.3%	Open the original filing on SEC.gov
Feb 13	Baechler Guido	Chief Executive Officer	AGRANT	440,000	—	—	+266.6%	Open the original filing on SEC.gov
Feb 13	Lazar David E.	Director	AGRANT◆	1M	—	—	—	Open the original filing on SEC.gov
Feb 13	Lazar David E.	Director	AGRANT◆	1M	—	—	—	Open the original filing on SEC.gov
Feb 13	Lazar David E.	Director	AGRANT◆	1M	—	—	—	Open the original filing on SEC.gov
Oct 17, 2025	Donahue Kevin Michael	10% Owner	PBUY↺	685,000	$1.51	$1M	—	Open the original filing on SEC.gov

AGRANT◆—

Caragol William J · Chief Financial…Aug 11

212,500 sh

CCONV◆—

Lazar David E. · Chief Executive…Aug 5

124,700 sh

CCONV◆—

Lazar David E. · Chief Executive…Aug 5

1M sh

CCONV◆—

Lazar David E. · Chief Executive…Aug 5

1M sh

CCONV◆—

Lazar David E. · Chief Executive…Aug 5

1M sh

CCONV⚠$6.3B

Lazar David E. · Chief Executive…Aug 5

28.1M sh @ $225.00 · +103.9% own

CCONV$81M

Lazar David E. · Chief Executive…Aug 5

9M sh @ $9.00 · +50.0% own

CCONV$81M

Lazar David E. · Chief Executive…Aug 5

9M sh @ $9.00 · +100.0% own

CCONV$81M

Lazar David E. · Chief Executive…Aug 5

9M sh @ $9.00

AGRANT◆—

O'Rourke Peter · DirectorJul 31

190,840 sh

AGRANT◆—

Natan David · DirectorJul 31

190,840 sh

AGRANT◆—

Caragol William J · Chief Financial…Jul 31

212,500 sh

AGRANT◆—

Buffalino Louis R. · DirectorJul 31

425,000 sh

AGRANT—

Ben-Tzvi Avraham · DirectorJul 31

112,259 sh · +80.7% own

AGRANT◆↺—

O'Rourke Peter · DirectorJul 22

191,860 sh

AGRANT◆↺—

Natan David · DirectorJul 22

191,860 sh

AGRANT◆↺—

Caragol William J · Chief Financial…Jul 22

212,500 sh

AGRANT◆↺—

Buffalino Louis R. · DirectorJul 22

425,000 sh

AGRANT↺—

Ben-Tzvi Avraham · DirectorJul 22

112,859 sh · +81.1% own

AGRANT◆—

O'Rourke Peter · DirectorJul 6

112,859 sh

AGRANT—

Natan David · DirectorMay 8

137,141 sh

AGRANT—

Ben-Tzvi Avraham · DirectorMay 8

137,141 sh · +6,857% own

AGRANT◆$1.5M

Lazar David E. · Chief Executive…Apr 22

1M sh @ $1.50

AGRANT◆$1.5M

Lazar David E. · Chief Executive…Apr 22

1M sh @ $1.50

AGRANT—

Tibbitts Gregory J · DirectorFeb 13

45,000 sh · +413.8% own

AGRANT—

Dreismann Heinrich · DirectorFeb 13

45,000 sh · +228.4% own

AGRANT—

Caragol William J · Chief Financial…Feb 13

290,000 sh · +372.3% own

AGRANT—

Baechler Guido · Chief Executive…Feb 13

440,000 sh · +266.6% own

AGRANT◆—

Lazar David E. · DirectorFeb 13

1M sh

AGRANT◆—

Lazar David E. · DirectorFeb 13

1M sh

AGRANT◆—

Lazar David E. · DirectorFeb 13

1M sh

PBUY↺$1M

Donahue Kevin Michael · 10% OwnerOct 17, 2025

685,000 sh @ $1.51

Filing record

How quickly insiders here report their trades. Section 16 allows two business days from the transaction.

4 of 16 filings we hold were filed after the two-business-day deadline. The furthest past the deadline was 8 business days late.

Form 4 filings made after the two-business-day deadline, with the transaction date, the filing date and the number of business days between them.
Traded	Filed	Insider	Past deadline	Largest line	Source
Feb 13	Mar 2	Lazar David E.Director	8days	—	Filing ↗
May 8	May 25	Ben-Tzvi AvrahamDirector	8days	—	Filing ↗
May 8	May 20	Natan DavidDirector	6days	—	Filing ↗
Apr 22	Apr 27	Lazar David E.Chief Executive Officer	1day	$1.5M	Filing ↗

Lazar David E.Director

8days

Traded Feb 13 · filed Mar 2Filing ↗

Ben-Tzvi AvrahamDirector

8days

Traded May 8 · filed May 25Filing ↗

Natan DavidDirector

6days

Traded May 8 · filed May 20Filing ↗

Lazar David E.Chief Executive Officer

1day

Traded Apr 22 · filed Apr 27Filing ↗

Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings

Insiders at this company

Everyone who has filed a Form 4 for this issuer.

More biotech & pharma companies

Other issuers in the same industry with insider filings on record.

Whole sector →